Differentiation of Enteric Nervous System Lineages from Human Pluripotent Stem Cells.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
17 May 2024
Historique:
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

The human enteric nervous system, ENS, is a large network of glial and neuronal cell types with remarkable neurotransmitter diversity. The ENS controls bowel motility, enzyme secretion, and nutrient absorption and interacts with the immune system and the gut microbiome. Consequently, developmental and acquired defects of the ENS are responsible for many human diseases and may contribute to symptoms of Parkinson's disease. Limitations in animal model systems and access to primary tissue pose significant experimental challenges in studies of the human ENS. Here, a detailed protocol is presented for effective in vitro derivation of the ENS lineages from human pluripotent stem cells, hPSC, using defined culture conditions. Our protocol begins with directed differentiation of hPSCs to enteric neural crest cells within 15 days and yields diverse subtypes of functional enteric neurons within 30 days. This platform provides a scalable resource for developmental studies, disease modeling, drug discovery, and regenerative applications.

Identifiants

pubmed: 38829111
doi: 10.3791/66133
doi:

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Homa Majd (H)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco; homa.majd@ucsf.edu.

Mikayla N Richter (MN)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco.

Ryan M Samuel (RM)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco.

Ali Kalantari (A)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco.

Jonathan T Ramirez (JT)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco.

Faranak Fattahi (F)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco; Program in Craniofacial Biology, University of California, San Francisco; faranak.fattahi@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH